Andrew Smith, Associate Professor of Bioengineering, has recently led and published a study in which his team developed a novel type of quantum dots (QDs) with short-wave infrared (SWIR) emission. The SWIR-QDs are used for imaging single molecules in tissue and offer a large spectral range. The probes are expected to improve the clinical diagnosis of cancer. In future studies, Smith will develop lower-cost instrumentation for the probes and apply materials for tissue-mapping.

Access the full paper published in the Journal of the American Chemical Society.

Written by Susan McKenna, Bioengineering

Link to the original article.